EcoDrugPlus

Carbonic Anhydrase 6

Ensembl ID : ENSOJAG00000007411
Gene Symbol: CA6
1 Cross references
215 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSOJAG00000016466
Gene Symbol: CA4A
1 Cross references
212 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSOJAG00000005180
Gene Symbol: CA4C
1 Cross references
79 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSOJAG00000007673
Gene Symbol: CA7
1 Cross references
221 Possible Orthologues:

Carbonic Anhydrase Va

Ensembl ID : ENSOJAG00000003273
Gene Symbol: CA5A
1 Cross references
231 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSOJAG00000019663
Gene Symbol: CA14
1 Cross references
210 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSOJAG00000008427
Gene Symbol: CSNK1E
1 Cross references
211 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSOJAG00000006742
Gene Symbol: CSNK1E
1 Cross references
196 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSOJAG00000011163
Gene Symbol: CASP9
1 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSOJAG00000020667
Gene Symbol: COMTB
1 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSOJAG00000008944
Gene Symbol: CTSC
1 Cross references
237 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSOJAG00000006038
Gene Symbol: CTSK
1 Cross references
222 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).